Angioedemaassociated with angiotensin converting enzymeinhibitors is a rare adverse reaction. It commonly involves the face, oropharyngeal and laryngeal tissues. To our knowledge, angioedemaof the abdominal viscera related to angiotensin converting enzymeinhibitors has not been reported previously. Wepresent a rare case ofa patient whohad episodes ofangioedema and abdominal pain with ascites probably related to the ACEinhibitor captopril. (Internal Medicine 32: 424-426, 1993) 
Introduction
Angiotensin-converting enzyme (ACE) inhibitors have been available as antihypertensive agents since 1980. Dry cough, excessive hypotension, hyperkalemia and angioedema have been described as adverse reactions (1, 2) . Angioedema associated with ACEinhibitors has an estimated incidence of 0. 1-0.2% in the general population (3, 4) . It usually occurs in the oropharyngeal or laryngeal tissues and may result in fatal acute airway obstruction. To our knowledge, there has been no previous report on abdominalviscera angioedemarelated to ACE inhibitors. We present a patient who had episodes of angioedema and abdominal pain with ascites probably related to ACE inhibitor.
Case Report
A 48-year-old Japanese womanwith essential hypertension was started on captopril 12.5 mg three times daily in March 1990. The second day of medication, the patient complained of mild abdominal pain. Gastroendoscopy and abdominal ultrasound imaging disclosed no definite abnormality. The patient' s complaint subsided within a few days. For four months, the patient achieved excellent control of her hypertension. In July 1990, remarkable lip swelling suddenly developed ( Fig. 1 ) but disappeared the next day. The captopril was continued. Six days later, the patient was admitted to our hospital because ofcrampy abdominal pain, nausea and vomiting. Scout film of the abdomen and abdominal ultrasound imaging revealed no abnormality. After the patient fasted, with captopril also withheld, the symptoms subsided within a day. Seven days later, the patient was well and could be discharged. Medication of captopril was resumed. Onemonthlater, she wasagain admitted to our hospital because of lower abdominal pain, nausea, and vomiting.
Onadmission, her vital signs were as follows: temperature 36.6°C, pulse 78/minutes, and blood pressure 120/90 mmHg. From the Department of Internal Medicine of Tsurugi General Hospital, Ishikawa Received for publication October 5, 1992 ; Accepted for publication April 9, 1993 Reprint requests should be addressed to Dr. Masami Matsumura, the Second Department of Internal Medicine, School of Medicine, Kanazawa University, Takaramachi 13-1 , Kanazawa-city 920, Japan On physical examination, no rash or swelling was observed. The abdomen was moderately distended and the right lower quadrant tender, but there was no muscular rigidity. Urinalysis was negative. The hematocrit was 36.9%. The white-cell count was 6,100, with 68% neutrophils, 22% lymphocytes, 8% monocytes and 2% eosinophils. Liver function was normal: GOT14 IU/1 and GPT ll IU/1. The urea nitrogen, creatinine, sodium, chloride, potassium, amylase, C3 , C4, and CH50 were all normal. Serum IgE was normal at 6.8 IU/ml. Scout film of the abdomen showed no abnormality. Abdominal ultrasound imaging revealed an excess of fluid distributed in the upper, lower abdomenand pelvic areas (Fig.  2 ). An edematous gastrointestinal wall was not apparent. The ascites collected from the peritoneal cavity appeared exudative ( Table 1) . Because of the episodes of lip swelling and recurrent abdominal pain, we suspected angioedema of the abdominal viscera caused by idiopathic form, hereditary form, or ACE inhibitors.
After admission, captopril was stopped. Wetreated the patient with nafamostat mesilate (50 mg i.v.), a serine protease inhibitory agent. The symptoms had almost disappeared the next day. Three days later, the ascites had completely disappeared on the abdominal ultrasound imaging. On admission, serum Cl esterase inhibitor (Cl INH) was normal at 16.5 mg/ dl (normal, 15 to 35 mg/dl) and its activity was normal at 86% (normal, 80 to 130%). Hereditary angioedema was excluded. Liver diseases, pancreas diseases, infectious diseases, collagen diseases, and malignancies were ruled out by further examina- another hereditary basis different from C l INH deficiency. The patients with a history of idiopathic angioedema may be at increased risk for the development of angioedema associated with ACEinhibitors. Angioedema induced by ACEinhibitors has an estimated incidence ofO. 1-0.2% (3 , 4) . It has been reported that angioedema occurs without gender preference or dose-response relationship (3). To our knowledge, angioedema associated with ACE inhibitors has not been reported in Japan, despite the widespread use of ACEinhibitors in this country. This low incidence in Japan may be attributable to racial differences. The angioedema usually occurs with the start of medication (3, 8) . Chin and Buchan (9) reported a case that had two separate episodes of angioedema occurring manymonths apart after long-term use of the ACEinhibitor enarapril. Our case also had episodes of angioedema and abdominal pain with ascites after several months use of captopril. Thus it is important to be aware that angioedemamayoccur even after the long-term use of an ACE inhibitor.
The commonlocations of angioedema associated with ACE inhibitors include the lip, tongue, oropharyngeal, and laryngeal tissues (8) . (14) reported that the infusion of nafamostat mesilate into a patient with a hereditary angioedema increased the high molecular kininogen level and improved the angioedema. Although the effect of nafamostat mesilate in our case was uncertain, in view of the speculated mechanismof angioedema associated with ACEinhibitors , nafamostat mesilate may be effective in its treatment.
In summary, we report a rare case of angioedema and abdominal pain with ascites probably related to the ACE inhibitor captopril. Angioedemaof the abdominal viscera related to ACEinhibitor was suspected as the cause of the abdominal pain with ascites. Recognition of angioedema and abdominal pain occurring after long-term use of an ACE inhibitor is important.
